GNTbm-CC-02

N/A

Report date: 2022/07/18 16:40:20

Base Information

Drug NameGNTbm-CC-02
Drug Alias NameGNTbm-CC-02
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesGreat Novel Therapeutics Biotech & Medicals Corp
China Registration ClassN/A

Develop Information

Active CompaniesGreat Novel Therapeutics Biotech & Medicals Corp
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A